ArticleMedicine2026
The development trajectory of self-advocacy in patients with adjuvant chemotherapy after breast cancer surgery and its predictors.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is still a lack of research to analyze the development trajectory of the level of self-advocacy and related factors in patients with adjuvant chemotherapy after breast cancer. The present study aims to analyze the development trajectory of self-advocacy and its predictors in patients with adjuvant chemotherapy after breast cancer. A total of 242 breast cancer patients admitted to our hospital from January 2024 to December 2024 were collected. A total of 200 patients participated in 4 follow-up surveys before chemotherapy (T1), early chemotherapy (T2), mid-chemotherapy (T3), and late chemotherapy (T4), with a valid questionnaire recovery rate of 82.64%. Latent class growth analysis was used to analyze the development trajectory of self-advocacy in patients with postoperative adjuvant chemotherapy for breast cancer, and the influencing factors' development trajectory of self-advocacy level was analyzed by binary logistic regression. The self-advocacy scores of breast cancer patients with adjuvant chemotherapy after surgery at T1 to T4 were (56.49 ± 13.89), (56.69 ± 14.50), (57.15 ± 16.89), and (56.59 ± 19.96) points, respectively. The scores of self-advocacy at the 4 time points were positively correlated (P < .05), which met the premise of model fitting. The development trajectory of self-advocacy of patients with adjuvant chemotherapy after breast cancer surgery was plotted, and the patients were divided into high self-advocacy group (n = 85) and low self-advocacy group (n = 115) according to the development trajectory. Multivariate logistic regression analysis showed that breast-conserving surgery, education, Consumer Experiences of Stigma Questionnaire score, and Nurse Patient Trust Scale score were the influencing factors of the development trajectory of self-advocacy in patients with adjuvant chemotherapy after breast cancer surgery (P < .05). Breast-conserving surgery, education, Consumer Experiences of Stigma Questionnaire score, and Nurse Patient Trust Scale score were the influencing factors of the development trajectory of self-advocacy in patients with adjuvant chemotherapy after breast cancer surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.